Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T22:22:26.587Z.
Calculation as of: 2026-10-06T22:22:26.587Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e0aae41c25609cbe98cd8c59fbdc20e812e1ea61d6a67e0b8df2c56749153647
EARNINGS YIELD
N/A
Kyverna Therapeutics, Inc.
Market Cap
$374.50M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$376.01M
Earnings Yield
N/A
TTM Avg
0.02%
3Y Avg
0.02%
5Y Avg
0.02%
Market Cap
$369.50M
Earnings Yield
N/A
TTM Avg
11.40%
3Y Avg
11.40%
5Y Avg
11.40%
Market Cap
$380.37M
Earnings Yield
N/A
TTM Avg
1.96%
3Y Avg
1.22%
5Y Avg
1.02%
Market Cap
$359.53M
Earnings Yield
N/A
TTM Avg
0.64%
3Y Avg
0.64%
5Y Avg
0.64%
Market Cap
$355.43M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | $374.50M | N/A | N/A | N/A | N/A |
| Canopy Growth Corporation (CGC)vs › | $376.01M | N/A | 0.02% | 0.02% | 0.02% |
| Zura Bio Limited (ZURA)vs › | $376.19M | N/A | N/A | N/A | N/A |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $369.50M | N/A | 11.40% | 11.40% | 11.40% |
| Orthofix Medical Inc. (OFIX)vs › | $380.37M | N/A | 1.96% | 1.22% | 1.02% |
| REGENXBIO Inc. (RGNX)vs › | $385.15M | N/A | 7.77% | 7.77% | 5.78% |
| Opus Genetics, Inc. (IRD)vs › | $361.64M | N/A | N/A | N/A | N/A |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $359.53M | N/A | 0.64% | 0.64% | 0.64% |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $355.43M | N/A | N/A | N/A | N/A |
| Viemed Healthcare, Inc. (VMD)vs › | $355.36M | 3.90% | 4.08% | 3.68% | 3.48% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
